An interventional study of Audiovisual Virtual Reality Distraction in Urolithiasis and Procedural Pain, sponsored by Burdur Mehmet Akif Ersoy University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Burdur Mehmet Akif Ersoy University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 27 studies in Urolithiasis with a site in Turkey — 10 open to participants now, 10 under way, none of them phase 3. Urolithiasis · Turkey.
Among the 27 studies in Urolithiasis with a site in Turkey, this one is the 12th largest by enrollment of the 17 interventional ones that give a count, is one of 9 that started in 2026, is one of 15 with no phase, and was the 27th registered.
257 studies on the registry are indexed under Urolithiasis; 69 are open to participants now.
Browse Urolithiasis studies →10 of the 27 studies in Urolithiasis with a site in Turkey are open now. Recruiting first, the newest first:
Aydin Adnan Menderes University · Sites in Turkey
Ages 18+
Trabzon Kanuni Education and Research Hospital · Sites in Turkey
Ages 18–65
Hitit University · Sites in Turkey
Ages 18+
Namik Kemal University · Sites in Turkey
Ages 18+
Namik Kemal University · Sites in Turkey
Ages 18+ · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 38 Urolithiasis studies recruiting now, 18 (47%) set no upper age limit and 12 (32%) stop at 75 or younger; 5 take children under 18; 4 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
27 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 9 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 67 is below the median of 100 across 186 interventional studies indexed under Urolithiasis.
Median enrollment 80 across the 17 interventional studies, 202 across the 10 observational. Of the 16 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 27 has an industry lead sponsor. The 10 most frequent:
Burdur Mehmet Akif Ersoy University is the lead sponsor of 49 studies on the registry; 17 are open to participants now.
Burdur Mehmet Akif Ersoy University has 1 study filed under Urolithiasis — fewer than ten, so there is no comparison to draw.
6 of the studies in Urolithiasis with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07763613Trabzon Kanuni Education and Research HospitalClinical Evaluation of the Pelvic Floor Fatigue Index (PFFI) | 2026-12-25 |
| NCT07512297University of GaziantepPain Control During ESWL Using Non-Opioid Analgesics | 2027-01-01 |
| NCT07736924Emrah Kızılay2D:4D Digit Ratio and Urinary Stone Disease | 2027-01-31 |
| NCT07655050Hitit UniversityAntibiotic Irrigation and Suction Ureteral Access Sheath in RIRS | 2027-02-08 |
| NCT07859436Aydin Adnan Menderes UniversityHuman Voice vs AI-Cloned Voice Audio Added to Written Consent Before Ureteroscopy or Retrograde Intrarenal Surgery (AUDIO-CONSENT) | 2027-03 |
Add all 6 to your calendar (.ics) → With an account.
Among the 27 studies in Urolithiasis with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this study was to learn whether virtual reality could reduce pain and improve comfort during shock wave treatment for urinary tract stones. This treatment is called extracorporeal shock wave lithotripsy (ESWL). It uses shock waves from outside the body to break stones into smaller pieces.
The main questions were:
Participants were assigned by chance to one of two groups. One group used a virtual reality headset to watch a nature-themed video with sound during treatment. This group also received usual care. The other group received usual care without virtual reality.
Participants in both groups rated their pain and comfort from 0 to 10 before and after treatment. The research team also measured their vital signs at these times.
The study compared these measures between the two groups to assess the effects of adding virtual reality to usual care.
Pain and discomfort during extracorporeal shock wave lithotripsy may affect patients' experience of treatment. Audiovisual virtual reality provides an immersive distraction that may shift attention away from the procedure. This study evaluated virtual reality as a nonpharmacological nursing intervention, with a focus on patient-reported pain and comfort and physiological responses to treatment.
A computer-generated allocation sequence was created using Research Randomizer to assign participants to the intervention or control group. The virtual reality content consisted of a nature-themed video with sound selected by the research team. The intervention was delivered during the ESWL session.
A structured patient information form was used to record demographic and clinical characteristics relevant to the treatment experience. These included age, sex, body mass index, stone size, stone location, skin-to-stone distance, and stone density. Assessments were conducted at corresponding stages of care in both groups to support comparison of their responses.
The evaluation focused on differences between groups and changes from before to after ESWL. The study hypothesis was that participants receiving audiovisual virtual reality would report less pain and greater comfort than participants receiving routine care alone. Vital signs were assessed to explore the physiological effects associated with the intervention.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants received routine care and watched a nature-themed video with sound through a virtual reality headset during extracorporeal shock wave lithotripsy (ESWL).
Behavioral: Audiovisual Virtual Reality Distraction
Participants received routine care during extracorporeal shock wave lithotripsy (ESWL), without virtual reality or an additional study-specific distraction intervention.
Participants watched a nature-themed video with accompanying sound through a virtual reality headset during extracorporeal shock wave lithotripsy (ESWL). The audiovisual content was selected by the research team and provided as a distraction intervention in addition to routine care.
Pain Intensity
Participants rated their pain intensity immediately after ESWL on a scale ranging from 0 (no pain) to 10 (worst pain). Higher scores indicated greater pain intensity. Scores were compared between the virtual reality and routine care groups.
Time frame: Immediately after completion of ESWL on Day 1.
Patient Comfort
Participants rated their comfort immediately after ESWL on a scale ranging from 0 to 10. Higher scores indicated greater comfort. Scores were compared between the virtual reality and routine care groups.
Time frame: Immediately after completion of ESWL on Day 1.
Systolic Blood Pressure
Systolic blood pressure was recorded in millimeters of mercury (mmHg) before and after ESWL. Measurements were compared between the virtual reality and routine care groups.
Time frame: Periprocedural (Day 1: before the start of ESWL and after completion of ESWL).
Diastolic Blood Pressure
Diastolic blood pressure was recorded in millimeters of mercury (mmHg) before and after ESWL. Measurements were compared between the virtual reality and routine care groups.
Time frame: Periprocedural (Day 1: before the start of ESWL and after completion of ESWL).
Pulse Rate
Pulse rate was recorded in beats per minute before and after ESWL. Measurements were compared between the virtual reality and routine care groups.
Time frame: Periprocedural (Day 1: before the start of ESWL and after completion of ESWL).
Plan to share: No — There is no plan to share individual participant data with other researchers. Study findings will be disseminated through scientific publications in aggregate form, without identifying individual participants.
Ran from Jan 2026 to primary completion in Oct 2026, 8 months.
Of 88 non-industry interventional studies with no phase under Urolithiasis, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 39. This study's 8 months is below that.
Counting every sponsor, half of 98 studies reached it within 19 months; a quarter within 8 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Burdur Mehmet Akif Ersoy University